The Lyophilisation market predicted to reach $3.09bn in 2014 with revenues showing growth to 2024

Join industry experts at the 2nd annual Lyophilisation conference. Gain insight into the opportunities in this fast-moving market & take a bold approach and navigate challenges within current technologies, regulations, high costs and formulation
 
 
Untitled-3
Untitled-3
 
Spread the Word
Listed Under

Tags:
Technologies
Pharmaceutical
Protein
Biopharmaceutical
Methodologies

Industrys:
Medical
Science

Location:
London - England - UK

LONDON - March 14, 2014 - PRLog -- The global lyophilisation for pharmaceuticals products and services market is predicted to reach $3.09bn in 2014 with revenues showing strong growth to 2024. With increasing numbers of proteins being discovered, the importance of lyophilisation is coming to the fore, for example, as a means of extending the shelf life of pharmaceutical and biopharmaceutical products.
(Source: Visiongain, The Global Lyophilisation for Pharmaceuticals products and services Market will reach $3.09BN in 2014 according to new visiongain report (http://www.visiongain.com/Press_Release/572/The-Global-Lyophilisation-for-Pharmaceuticals-products-and-services-Market-will-reach-3-09BN-in-2014-according-to-new-visiongain-report), 2014)

SMi invites you to attend the 2nd annual Lyophilisation conference on 7-8 July 2014, London. This event will provide an update on methodologies for lyophilisation and examine how to mitigate risks in production. Join our Lyophilisation forum and gain insight into current successes and challenges faced by pharmaceuticals and biopharmaceuticals.

Key Speakers Include

•          Sune Andersen, Principal Scientist, Novo Nordisk

•          Patrick Garidel, Associate Director, Protein Science, Boehringer Ingelheim

•          Julie Pagenaud, Sterile Product Manufacturing Manager, Ipsen

•          Massimo Rastelli, Project Leader BioPharm, GlaxoSmithKline

•          Andrea Weiland, CEO, Explicat Pharma

•          Mark Yang, Director of Fill Finish Development, Genzyme

•          Bertie Daly, Associate Director, Alexion Pharmaceuticals

•          Jamie Biddlecombe, Formulation Development Scientist, MedImmune

•          Jason Gray, Consultant, Allembis (ex-Merck)

•          Professor Dr Thomas de Beer, Laboratory of Process Analytical Technology, Ghent University

•          Dr Rongjun Chen, Lecturer in Chemical Engineering, Imperial College London

Key Topic Insights in 2014 include:

•          First hand case studies from leading experts in lyophilisation

•          Evaluate practical guidance from both industry and academics

•          Analyse ways to ensure good product quality at the end of the cycle

•          Discover the fastest way to delivery within a lyophilisation cycle

•          How to optimise cycles of products on the market

For more information and full programme details please visit: http://www.smi-online.co.uk/2014lyophilisation.asp

Alternatively please contact John Collins on tel +44(0) 207 827 6734 | email jcollins@smi-online.co.uk

Contact
John Collins
jcollins@smi-online.co.uk
End
Source:
Email:***@smi-online.co.uk
Posted By:***@smi-online.co.uk Email Verified
Tags:Technologies, Pharmaceutical, Protein, Biopharmaceutical, Methodologies
Industry:Medical, Science
Location:London - England - United Kingdom
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
SMi Group Ltd. PRs
Trending News
Top Daily News
Top Weekly News



Like PRLog?
9K2K1K
Click to Share